Home>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>AZD1208

AZD1208 (Synonyms: AZD 1208;AZD-1208)

Catalog No.GC12660

A pan-Pim kinase inhibitor

Products are for research use only. Not for human use. We do not sell to patients.

AZD1208 Chemical Structure

Cas No.: 1204144-28-4

Size Price Stock Qty
10mM (in 1mL DMSO)
$59.00
In stock
10mg
$59.00
In stock
25mg
$123.00
In stock
50mg
$179.00
In stock
200mg
$468.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Protocol

Kinase experiment [1]:

Preparation Method

To determine inhibition constants (Ki), 50% inhibition concentration (IC50) values were acquired at a series of ATP concentrations and compound doses with 1nM enzyme and 1.5mM full-length BAD substrate in 50mM N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, 1mM dithiothreitol, 0.01% Tween 20, 50mg/mL bovine serum albumin, and 10mM MgCl2

Reaction Conditions

1nM enzyme

Applications

AZD1208 is a potent ATP-competitive inhibitor of all three Pim kinase isoforms. The Ki values were determined to be 0.1nM for Pim-1, 1.92nM for Pim-2, and 0.4nM for Pim-3. In enzymatic assays carried out at a concentration of ATP that leads to half-maximal reaction velocity, AZD1208 inhibited kinase activity with an IC50 of 0.4nM for Pim-1, 5.0nM for Pim-2, and 1.9nM for Pim-3. In enzyme assays using 5mM ATP, the high end of physiologic ATP concentration in human cells, the IC50 values were 2.6nM for Pim-1, 164nM for Pim-2, and 17nM for Pim-3.

Cell experiment [2]:

Cell lines

MEC-1 cell line (derived from a patient with B-chronic lymphocytic leukemia)

Preparation Method

The cells were maintained in RPMI 1640 medium supplemented with 10% FBS serum with 5% carbon dioxide at 37℃ and maintained at 106 cells/mL.

Reaction Conditions

3 and 10µM AZD1208

Applications

MEC-1 cells treated with either AZD1208 concentration had less cell growth at all three time points compared to the MEC-1 cells treated with DMSO. At 48 hours, 3µM AZD1208 and at 72 hours both 3 and 10µM AZD1208 were significantly different than DMSO control. The cell death rate in MEC-1 cells treated with 10µM AZD1208 ranged from 6% to 12% across all three time points.

Animal experiment [3]:

Animal models

Six-week-old female BALB/c nude mice

Preparation Method

The mice were injected subcutaneously in the right flank with 7×107 of SNU-638 cells in 100µL of PBS. After implantation of the tumor cells, the tumor sizes were measured every other day, and the body weight of each mouse was determined twice per week. The mice were randomly divided into two groups (five mice per group) when tumor volumes reached 200mm3, and 45mg/kg of AZD1208 were administered via oral gavage once daily for 28 consecutive days. The control group was treated with vehicle alone (1mM histidine, 130mM Glycine, 5% sucrose in water).

Dosage form

45 mg/kg,oral gavage once daily for 28 consecutive days

Applications

AZD1208 significantly delayed tumor growth. The doubling time of tumor volume with vehicle treatment was 17 days, while the time to 2-fold increase of tumor volume with AZD1208 treatment was observed after 31 days, which supports the delay of tumor growth by AZD1208 treatment. Furthermore, AZD1208 treated mice showed lower Ki-67 expression, suggesting lower proliferation ability compared with non-treated mice. These data demonstrated the antitumor effects of AZD1208 in a gastric cancer model.

References:

[1]. Keeton EK, McEachern K, et al. AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. Blood. 2014;123(6):905-913.

[2]. Cervantes-Gomez F, Stellrecht CM, et al. PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells. Oncotarget. 2019;10(29):2793-2809. Published 2019 Apr 19.

[3]. Lee M, Lee KH, et al. Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells. Cancer Res Treat. 2019;51(2):451-463.

Background

AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor, with IC50 values of 0.4, 5, and 1.9nM for PIM1, PIM2, and PIM3, respectively[1,2]. AZD1208 is a thiazolidine that is known for its anti-cancer activity[3]

AZD1208 has anti-adipogenic and lipolytic effects on 3T3-L1 adipocytes through control of the expression and/or phosphorylation levels of PPAR-c, C/EBP-a, FAS, ACC, perilipin A, STAT-3, AMPK and HSL, that advocate AZD1208 as a potential therapeutics for the treatment of obesity[3]. AZD1208 resulted in suppression of mTOR signaling, including inhibition of protein phosphorylation of mTOR(Ser2448), p70S6K(Thr389), S6(Ser235/236) and 4E-BP1(Ser65)[4]. Treatment with AZD1208 alone induced considerable cell death through autophagy in gastric cancer cells. AZD1208 combines with an Akt inhibitor (AZD5363) showed synergistic antitumor effects through regulation of the DNA damage repair pathway[5]

AZD1208 dose-dependent inhibits the growth of MOLM-16 xenograft tumors in vivo. Treatment with 10mg/kg or 30mg/kg of AZD1208 led to 89% tumor growth inhibition or slight regression, respectively[2]. AZD1208 decreased the growth of tumors comprised of hepatoblastoma CD133-enriched cells, with 57% of the animals experiencing complete tumor regression in a vivo xenograft model[6]. AZD1208 was generally tolerated in patients with heavily pretreated AML (120–900 mg dose range) and advanced solid malignancies (120–800 mg dose range). AZD1208 increased CYP3A4 activity after multiple dosing, resulting in increased drug clearance[6]

References:
[1]. Cervantes-Gomez F, Stellrecht CM, et al. PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells. Oncotarget. 2019;10(29):2793-2809. Published 2019 Apr 19.
[2]. Keeton EK, McEachern K, et al. AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia. Blood. 2014;123(6):905-913
[3]. Park YK, Obiang-Obounou BW, et al. AZD1208, a pan-Pim kinase inhibitor, inhibits adipogenesis and induces lipolysis in 3T3-L1 adipocytes. J Cell Mol Med. 2018;22(4):2488-2497.
[4]. Chen LS, Yang JY, et al. Protein profiling identifies mTOR pathway modulation and cytostatic effects of Pim kinase inhibitor, AZD1208, in acute myeloid leukemia. Leuk Lymphoma. 2016;57(12):2863-2873.
[5]. Lee M, Lee KH, et al. Pan-Pim Kinase Inhibitor AZD1208 Suppresses Tumor Growth and Synergistically Interacts with Akt Inhibition in Gastric Cancer Cells. Cancer Res Treat. 2019;51(2):451-463.
[6]. Stafman LL, Williams AP, et al. Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma. Transl Oncol. 2019;12(2):200-208.
[7]. Cortes J, Tamura K, et al. Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. Br J Cancer. 2018;118(11):1425-1433.

Chemical Properties

Cas No. 1204144-28-4 SDF
Synonyms AZD 1208;AZD-1208
Chemical Name (5E)-5-[[2-[(3R)-3-aminopiperidin-1-yl]-3-phenylphenyl]methylidene]-1,3-thiazolidine-2,4-dione
Canonical SMILES C1CC(CN(C1)C2=C(C=CC=C2C=C3C(=O)NC(=O)S3)C4=CC=CC=C4)N
Formula C21H21N3O2S M.Wt 379.48
Solubility ≥ 18.95 mg/mL in DMSO Storage Store at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.6352 mL 13.1759 mL 26.3518 mL
5 mM 0.527 mL 2.6352 mL 5.2704 mL
10 mM 0.2635 mL 1.3176 mL 2.6352 mL
  • Molarity Calculator

  • Dilution Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Reviews

Review for AZD1208

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for AZD1208

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.